BLFS

Biolife Solutions Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↑ 8/10
  • Value↓ 0/10
Biolife Solutions sales and earnings growth
BLFS Growth
Good
  • Revenue Y/Y↑ 24.05%
  • EPS Y/Y↑ 73.91%
  • FCF Y/Y↓ -124.97%
Biolife Solutions gross and profit margin trends
BLFS Profitability
Neutral
  • Gross margin ↑ 64.00%
  • EPS margin↓ -3.00%
  • ROIC 5Y↓ -27.88%
Biolife Solutions net debt vs free cash flow
BLFS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1.9

Biolife Solutions stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Instruments & Supplies stocks